Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Raffaella Di Monda
Observed name:
R. Di Monda
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0009-0002-3710-093X
Observed ORCID:
0009-0002-3710-093X
OpenAlex ID:
A5117577531
The long road after breast cancer: survivorship issues and long-term treatment effects in young women
2026
·
Martina Pagliuca
, Roberto Buonaiuto
, et al.
·
Frontiers in Oncology
·
1
PDF
3376P Structured multidisciplinary pathway for hereditary breast cancer: A five-year institutional evaluation
2026
·
M. Pensabene
, A. Calabrese
, et al.
·
Annals of Oncology
Decoding Mitophagy in Breast Cancer: Biological Mechanisms, Dual Roles, and Clinical Implications
2026
·
Silvia Zunico
, Giorgia Pisano
, et al.
·
Cells
CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety
2026
·
Claudia von Arx
, Alessandra Calabrese
, et al.
·
Clinical Breast Cancer
678eTiP A multimodal and multicenter approach for biobanking of biological materials and associated clinical data to improve rehabilitation in breast cancer patients with cognitive impairment – COMBINE
2026
·
R. Di Monda
, A. Calabrese
, et al.
·
ESMO Open
557eP OVAL-T-Dxd: Real-world assessment of ovarian function suppression (OFS) during trastuzumab deruxtecan (T-Dxd) therapy in premenopausal, hormone-receptor–positive (HR+/HER2-Low) metastatic breast cancer (mBC)
2026
·
S. Parola
, O. Tinelli
, et al.
·
ESMO Open
PDF
373P Association between CDK4/6 inhibitor (i) clinical outcomes and breast cancer (BC) histotypes
2025
·
C. von Arx
, A. Calabrese
, et al.
·
ESMO Open
PDF
286P Assessment of non-genetic factors with breast cancer risk in women BRCA carriers
2025
·
A. Calabrese
, M. Fordellone
, et al.
·
ESMO Open
Show more works
View as search
Works count:
8
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type